Molecular	JJ	molecular O TermTag
targets	NNS	target O TermTag
in	IN	in O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
:	:	: : NUPOS
the	DT	the O TermTag
myofibroblast	NN	myofibroblast O TermTag
in	IN	in O TermTag
focus	NN	focus O TermTag
.	.	. . NUPOS

Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
one	CD	one O TermTag
of	IN	of O TermTag
a	DT	a dt NUPOS
group	NN	group O TermTag
of	IN	of O TermTag
interstitial	JJ	interstitial O TermTag
lung	NN	lung O TermTag
diseases	NNS	disease O TermTag
that	WDT	that O TermTag
are	VBP	be O TermTag
characterized	VBN	characterize O TermTag
by	IN	by O TermTag
excessive	JJ	excessive O TermTag
matrix	NN	matrix O TermTag
deposition	NN	deposition O TermTag
and	CC	and O TermTag
destruction	NN	destruction O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
normal	JJ	normal O TermTag
lung	NN	lung O TermTag
architecture	NN	architecture O TermTag
.	.	. . NUPOS

Long-term	JJ	long-term O TermTag
survival	NN	survival O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
patients	NNS	patient O TermTag
is	VBZ	be O TermTag
poor	JJ	poor O TermTag
,	,	, , NUPOS
with	IN	with O TermTag
a	DT	a dt NUPOS
5-year	JJ	5-year O TermTag
survival	NN	survival O TermTag
rate	NN	rate O TermTag
of	IN	of O TermTag
only	RB	only O TermTag
20	CD	20 O TermTag
%	NN	% NN PennPOS
.	.	. . NUPOS

Despite	IN	despite O TermTag
a	DT	a dt NUPOS
lack	NN	lack O TermTag
of	IN	of O TermTag
evidence-based	JJ	evidence-based O TermTag
benefit	NN	benefit O TermTag
,	,	, , NUPOS
IPF	NN	IPF O TermTag
has	VBZ	have O TermTag
historically	RB	historically O TermTag
been	VBN	be O TermTag
treated	VBN	treat O TermTag
with	IN	with O TermTag
corticosteroids	NNS	corticosteroid O TermTag
and/or	CC	and/or O TermTag
cytotoxic	JJ	cytotoxic O TermTag
agents	NNS	agent O TermTag
such	JJ	such O TermTag
as	IN	as O TermTag
prednisone	NN	prednisone O TermTag
.	.	. . NUPOS

Given	VBN	give O TermTag
the	DT	the O TermTag
poor	JJ	poor O TermTag
efficacy	NN	efficacy O TermTag
of	IN	of O TermTag
these	DT	these O TermTag
drugs	NNS	drug O TermTag
,	,	, , NUPOS
novel	JJ	novel O TermTag
therapeutic	JJ	therapeutic O TermTag
strategies	NNS	strategy O TermTag
are	VBP	be O TermTag
required	VBN	require O TermTag
for	IN	for O TermTag
the	DT	the O TermTag
management	NN	management O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

This	DT	this O TermTag
demands	VBZ	demand O TermTag
a	DT	a dt NUPOS
better	JJR	good O TermTag
understanding	NN	understanding O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
molecular	JJ	molecular O TermTag
mechanisms	NNS	mechanism O TermTag
underlying	VBG	underlie O TermTag
the	DT	the O TermTag
pathogenesis	NN	pathogenesis O TermTag
and	CC	and O TermTag
progression	NN	progression O TermTag
of	IN	of O TermTag
this	DT	this O TermTag
disease	NN	disease O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
primary	JJ	primary O TermTag
effector	NN	effector O TermTag
cell	NN	cell O TermTag
in	IN	in O TermTag
fibrosis	NN	fibrosis O TermTag
is	VBZ	be O TermTag
the	DT	the O TermTag
myofibroblast	NN	myofibroblast O TermTag
;	:	; : NUPOS
these	DT	these O TermTag
cells	NNS	cell O TermTag
are	VBP	be O TermTag
highly	RB	high O TermTag
synthetic	JJ	synthetic O TermTag
for	IN	for O TermTag
collagen	NN	collagen O TermTag
,	,	, , NUPOS
have	VBP	have O TermTag
a	DT	a dt NUPOS
contractile	JJ	contractile O TermTag
phenotype	NN	phenotype O TermTag
,	,	, , NUPOS
and	CC	and O TermTag
are	VBP	be O TermTag
characterized	VBN	characterize O TermTag
by	IN	by O TermTag
the	DT	the O TermTag
presence	NN	presence O TermTag
of	IN	of O TermTag
alpha-smooth-muscle-actin	JJ	alpha-smooth-muscle-actin GENE TermTag
stress	NN	stress O TermTag
fibers	NNS	fiber O TermTag
.	.	. . NUPOS

They	PRP	they O TermTag
may	MD	may O TermTag
be	VB	be O TermTag
derived	VBN	derive O TermTag
by	IN	by O TermTag
activation/proliferation	NN	activation/proliferation O TermTag
of	IN	of O TermTag
resident	JJ	resident O TermTag
lung	NN	lung O TermTag
fibroblasts	NNS	fibroblast O TermTag
,	,	, , NUPOS
epithelial-mesenchymal	JJ	epithelial-mesenchymal O TermTag
differentiation	NN	differentiation O TermTag
,	,	, , NUPOS
or	CC	or O TermTag
recruitment	NN	recruitment O TermTag
of	IN	of O TermTag
circulating	VBG	circulate O TermTag
fibroblastic	JJ	fibroblastic O TermTag
stem	NN	stem O TermTag
cells	NNS	cell O TermTag
(	(	( ( NUPOS
fibrocytes	NNS	fibrocyte O TermTag
)	)	) ) NUPOS
.	.	. . NUPOS

From	IN	from O TermTag
a	DT	a dt NUPOS
therapeutic	JJ	therapeutic O TermTag
viewpoint	NN	viewpoint O TermTag
,	,	, , NUPOS
interfering	VBG	interfere O TermTag
with	IN	with O TermTag
the	DT	the O TermTag
pathways	NNS	pathway O TermTag
that	WDT	that O TermTag
lead	VBP	lead O TermTag
to	TO	to O TermTag
myofibroblast	JJ	myofibroblast O TermTag
expansion	NN	expansion O TermTag
should	MD	shall O TermTag
be	VB	be O TermTag
of	IN	of O TermTag
considerable	JJ	considerable O TermTag
benefit	NN	benefit O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
treatment	NN	treatment O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

This	DT	this O TermTag
review	NN	review O TermTag
will	MD	will O TermTag
highlight	VB	highlight O TermTag
some	DT	some O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
key	JJ	key O TermTag
molecules	NNS	molecule O TermTag
involved	VBN	involve O TermTag
in	IN	in O TermTag
this	DT	this O TermTag
process	NN	process O TermTag
and	CC	and O TermTag
the	DT	the O TermTag
clinical	JJ	clinical O TermTag
trials	NNS	trial O TermTag
that	WDT	that O TermTag
have	VBP	have O TermTag
ensued	VBN	ensue O TermTag
.	.	. . NUPOS

